General Announcement::Proposal to issue unsecured bonds under Regulation S of the U.S. Securities Act of 1933, as amended

Issuer & Securities

Issuer/ Manager
JUBILANT PHARMA LIMITED
Securities
JUBILANTP US$300M4.875%N211006 - XS1493722299 - 4X7B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
25-Feb-2019 08:52:28
Status
New
Announcement Sub Title
Proposal to issue unsecured bonds under Regulation S of the U.S. Securities Act of 1933, as amended
Announcement Reference
SG190225OTHRSYBH
Submitted By (Co./ Ind. Name)
Arun Kumar Sharma
Designation
Chief Financial Officer
Effective Date and Time of the event
25/02/2019 17:00:00
Description (Please provide a detailed description of the event in the box below)
We wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. February 25, 2019, approved the proposal to launch an offering of unsecured bonds (the Notes ) under Regulation S of the U.S. Securities Act of 1933, as amended. The Notes are proposed to be (i) issued to institutional investors outside India and (ii) listed and quoted on the Official List of the Singapore Exchange Securities Trading Limited.

The Company proposes to undertake meetings with one or more potential international institutional investors located in different jurisdictions pursuant to the approval of the Board of Directors for the offering of the Notes as stated below:

Date of Meetings Location of Meetings
February 26, 2019 - Singapore
February 27, 2019 - Hong Kong and London

The schedule of meetings may undergo change due to exigencies on the part of the investors or the Company.

A copy of the investor presentation to be shared with the investors during the meetings is attached herewith. Further, the investor presentation along with certain related additional information shall also be available on the website of the Company (www.jubilantpharma.com).

Upon completion of these investors meetings and the book building process, the Company is expected to price the issuance of the Notes. We will intimate the stock exchange upon completion of the pricing of the Notes once the Company has determined the final terms of such Notes, including the total amount of the securities proposed to be issued by way of the Notes.

The Company will provide further updates in this regard, if and when necessary.

We request you to take the same on record.

This notice is not for distribution in or into the United States. This notice is not an offer for sale of any securities in the United States or any jurisdiction. Securities may not be offered or sold in the United States or any jurisdiction absent registration or an exemption from registration under applicable laws and regulations. Any public offering of securities to be made in the United States would be made by means of a prospectus that would contain detailed information about the issuer, their management and their financial statements in compliance with all relevant laws. The issuer does not have any current intention to make any public offering of, or to register, any securities in the United States.

Attachments

JPL - SGX Intimation - 25.02.2019.pdf
Total size =4568K